Funds holding TScan Therapeutics Inc
ISIN US89854M1018 · United States
- Fund holders
- 21
- Of which ETFs
- 1 20 other funds
- Value held
- 3.6M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,500,337 | 1.5M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 577,585 | 583.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 556,653 | 590.1K $ | 0.01 % | as of Feb 27, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 271,444 | 287.7K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 116,037 | 117.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 105,400 | 106.5K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 87,566 | 92.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 72,914 | 77.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 46,729 | 47.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 39,500 | 39.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 33,788 | 34.1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 33,500 | 33.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 29,605 | 29.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 28,767 | 30.5K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 28,700 | 29K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 7,907 | 8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 7,100 | 7.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 3,238 | 3.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 1,200 | 1.3K $ | as of Feb 28, 2026 ↗ | |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 713 | 720.1 $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 268 | 310.9 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.09 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.01 % | as of Feb 27, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 21 | 0 | 3,548,951 | +4.4 % |
| 2026Q1 | 21 | -4 | 3,398,211 | -25.6 % |
| 2025Q4 | 25 | -31 | 4,568,638 | -14.6 % |
| 2025Q3 | 56 | -45 | 5,348,051 | -28.4 % |
| 2025Q2 | 101 | -3 | 7,472,698 | -1.4 % |
| 2025Q1 | 104 | -3 | 7,580,014 | +0.1 % |
| 2024Q4 | 107 | +61 | 7,569,485 | +41.5 % |
| 2024Q3 | 46 | +25 | 5,347,836 | +56.9 % |
| 2024Q2 | 21 | +3 | 3,407,807 | +1.9 % |
| 2024Q1 | 18 | +2 | 3,343,123 | +8.9 % |
| 2023Q4 | 16 | 3,068,715 |
Institutional managers
56 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Lynx1 Capital Management LP | 8,019,148 | 8.1M $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,564,290 | 5.6M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 2,784,792 | 2.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,840,952 | 1.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,460,285 | 1.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,364,783 | 1.4M $ | as of Mar 31, 2026 |
| Deer Management Co. LLC | 1,245,504 | 1.3M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,209,009 | 1.2M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 918,020 | 927.2K $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 808,356 | 816.4K $ | as of Mar 31, 2026 |
| DC Funds, LP | 630,000 | 630K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 616,952 | 623.3K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 378,960 | 383 $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 319,587 | 322.8K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 318,411 | 321.6K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 237,346 | 239.7K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 207,313 | 209.4K $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 201,987 | 201 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 173,643 | 175.4K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 157,228 | 158.8K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 144,421 | 145.9K $ | as of Mar 31, 2026 |
| BROWN BROTHERS HARRIMAN & CO | 143,051 | 144.5K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 134,001 | 135.3K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,900 | 113K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 97,448 | 98.4K $ | as of Mar 31, 2026 |
Declared shareholders of TScan Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.99 % | 5,578,288 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding TScan Therapeutics Inc". https://titelia.com/en/stocks/tscan-therapeutics-inc-US89854M1018